key: cord-0799866-5uwnyult
authors: Kinloch, Natalie N.; Ritchie, Gordon; Dong, Winnie; Cobarrubias, Kyle D.; Sudderuddin, Hanwei; Lawson, Tanya; Matic, Nancy; Montaner, Julio S.G.; Leung, Victor; Romney, Marc G.; Lowe, Christopher F.; Brumme, Chanson J.; Brumme, Zabrina L.
title: SARS-CoV-2 RNA quantification using droplet digital RT-PCR
date: 2020-12-22
journal: bioRxiv
DOI: 10.1101/2020.12.21.423898
sha: e86bbb193d7c8146416c9513fa86007bc98457e4
doc_id: 799866
cord_uid: 5uwnyult

Quantitative viral load assays have transformed our understanding of – and ability to manage − viral diseases. They hold similar potential to advance COVID-19 control and prevention, but SARS-CoV-2 viral load tests are not yet widely available. SARS-CoV-2 molecular diagnostic tests, which typically employ real-time reverse transcriptase-polymerase chain reaction (RT-PCR), yield semi-quantitative results only. Reverse transcriptase droplet digital PCR (RT-ddPCR), a technology that partitions each reaction into 20,000 nanolitre-sized droplets prior to amplification, offers an attractive platform for SARS-CoV-2 RNA quantification. We evaluated eight primer/probe sets originally developed for real-time RT-PCR-based SARS-CoV-2 diagnostic tests for use in RT-ddPCR, and identified three (Charité-Berlin E-Sarbeco and Pasteur Institute IP2 and IP4) as the most efficient, precise and sensitive for RT-ddPCR-based SARS-CoV-2 RNA quantification. Analytical efficiency of the E-Sarbeco primer/probe set, for example, was ~83%, while assay precision, as measured by the coefficient of variation, was ~2% at 1000 input copies/reaction. Lower limits of quantification and detection for this primer/probe set were 18.6 and 4.4 input SARS-CoV-2 RNA copies/reaction, respectively. SARS-CoV-2 RNA viral loads in a convenience panel of 48 COVID-19-positive diagnostic specimens spanned a 6.2log10 range, confirming substantial viral load variation in vivo. We further calibrated RT-ddPCR-derived SARS-CoV-2 E gene copy numbers against cycle threshold (Ct) values from a commercial real-time RT-PCR diagnostic platform. The resulting log-linear relationship can be used to mathematically derive SARS-CoV-2 RNA copy numbers from Ct values, allowing the wealth of available diagnostic test data to be harnessed to address foundational questions in SARS-CoV-2 biology.

Quantitative viral load assays have revolutionized our ability to manage viral diseases (1-71 6). While not yet widely available for SARS-CoV-2, quantitative assays could advance our 72 understanding of COVID-19 biology and inform infection prevention and control measures (7, 73 8) . Most SARS-CoV-2 molecular diagnostic assays however, which use real-time reverse 74 transcriptase PCR (RT-PCR) to detect one or more SARS-CoV-2 genomic targets using 75 sequence-specific primers coupled with a fluorescent probe, are only semi-quantitative. These 76 tests produce cycle threshold (C t ) values as readouts, which represent the PCR cycle where the 77 sample began to produce fluorescent signal above background. While each C t value decrement 78 corresponds to a roughly two-fold higher viral load (due to the exponential nature of PCR 79 amplification), C t values cannot be directly interpreted as SARS-CoV-2 viral loads without 80 calibration to a quantitative standard (9). Rather, C t values are interpreted as positive, 81 indeterminate or negative based on assay-specific cutoffs and evolving clinical guidelines. Due 82 to differences in nucleic acid extraction method, viral target and other parameters, C t values are 83 also not directly comparable across assays or technology platforms. 84

Reverse transcriptase droplet digital PCR (RT-ddPCR) offers an attractive platform for 85 SARS-CoV-2 RNA quantification (10, 11). Like real-time RT-PCR, ddPCR employs target-86 specific primers coupled with a fluorescent probe, making it relatively straightforward to adapt 87 assays. In ddPCR however, each reaction is fractionated into 20,000 nanolitre-sized droplets 88 prior to massively parallel PCR amplification. At end-point, each droplet is categorized as 89 positive (target present) or negative (target absent), allowing for absolute target quantification 90 using Poisson statistics. This sensitive and versatile technology has been used for mutation 91 detection and copy number determination in the human genome (12), target verification 92 consecutive 95% confidence intervals of copy number estimates outside those of the maximal 151 point-estimate. 152

The analytical efficiency of each primer/probe set to quantify SARS-CoV-2 RNA by ddPCR was determined using synthetic SARS-CoV-2 RNA standards at 1000 and 100 input 155 copies. A minimum of three (maximum four) technical replicates were performed at each 156 concentration. Analytical efficiency was calculated by dividing the measured SARS-CoV-2 copy 157 number by the expected input copy number, and multiplying by 100. Precision was expressed as 158 the coefficient of variation (CV), expressed as a percentage, across technical replicates. 159

The linear dynamic range (LDR) of each primer/probe set of interest was determined 161 across a serial 1:2 dilution series from 114,286 to 1.2 SARS-CoV-2 RNA copies/reaction. This 162 range of concentrations was chosen as it crosses the entire range of recommended input copies 163 for a ddPCR reaction seeking to quantify the target of interest (34). Reactions were performed in 164 duplicate. The upper and lower limits of quantification of (ULOQ and LLOQ, respectively) were 165 defined as the upper and lower boundaries of the concentration range over which the relationship 166 between measured and input SARS-CoV-2 RNA copies was linear. This was determined by 167 iteratively restricting the range of concentrations included in the linear regression of measured 168 versus input SARS-CoV-2 RNA copies to identify that which maximized the coefficient of 169 determination (R 2 ) value and minimized the residuals. 170

Assay analytical sensitivity, defined as the Lower Limit of Detection (LLOD), was 172 determined for primer/probe sets of interest by serially diluting synthetic SARS-CoV-2 RNA 173 standards to between 47.6 and 0.74 SARS-CoV-2 RNA copies/reaction. Between 6 and 18 174 technical replicates were performed for each dilution and results were analyzed using probit 175 regression. The LLOD, determined through interpolation of the probit curve, was defined as the 176 concentration of input SARS-CoV-2 RNA in a reaction where the probability of detection was 177 95%. 178

Optimized RT-ddPCR assays were applied to a convenience sample of 48 consecutive 180 remnant SARS-CoV-2-positive diagnostic nasopharyngeal swab specimens that were originally 181 submitted to the St. Paul's Hospital Virology Laboratory in Vancouver, Canada for diagnostic 182 testing using the Roche cobas® SARS-CoV-2 assay. For these samples, total nucleic acids were 183 re-extracted from 250µl remnant media using the BioMerieux NucliSens® EasyMag® and 184 eluted in 50µl. Eluates were aliquoted and frozen at -80°C prior to single use. SARS-CoV-2 copy 185 numbers were quantified by RT-ddPCR as described above. As our main goal was to 186 characterize the relationship between C t values and SARS-CoV-2 RNA levels without 187 confounding by extraction platform, quantity of input material or SARS-CoV-2 genomic target, 188 we re-tested these extracts using a commercial real-time RT-PCR SARS-CoV-2 diagnostic assay 189 that uses the E-Sarbeco primer/probe set (27) Finally, to be responsive to a recent recommendation that SARS-CoV-2 viral loads be reported 192 in terms of SARS-CoV-2 RNA copies per human cell equivalents (9), we measured human 193 cells/µl extract by ddPCR as previously described (32) 

Eight primer/probe sets originally developed for SARS-CoV-2 diagnostic testing by real 205 time RT-PCR were evaluated for use in RT-ddPCR (Table 1) . As these primer/probe sets vary in 206 sequence, amplicon length and SARS-CoV-2 genomic target, we first determined the acceptable 207 temperature ranges for reverse transcription (RT) and PCR annealing/extension. Most 208 primer/probe sets were tolerant to a wide temperature range, and background signal was 209

essentially zero at all temperatures tested ( Figure 1) . The E-Sarbeco primer/probe set for 210 example produced consistent amplitude profiles, copy number estimates and essentially zero 211 background at annealing/extension temperatures ranging from 50-63°C ( Figure 1A and data not 212 shown). The HKU-ORF primer/probe performed acceptably over a 50-60.5°C 213 annealing/extension range, but positive and negative droplet separation was insufficient at higher 214 temperatures ( Figure 1B ). Acceptable temperature ranges for each primer/probe set are shown in 215 Figure 1C . All subsequent experiments were performed at RT 42.7°C and annealing/extension 216 50.9°C except those for HKU-ORF and US-CDC-N1, which were performed at RT 45.7°C and 217 annealing/extension 55.1°C as informed by initial qualitative assessments. 218

We next evaluated the analytical efficiency of SARS-CoV-2 RNA quantification for each 220 primer/probe set, calculated as the percentage of input viral RNA copies detected by the assay. 221

We also evaluated precision, calculated as the dispersion of measured copies around the mean 222 (coefficient of variation, CV). Analytical efficiency and precision were evaluated at 1000 and 223 100 SARS-CoV-2 RNA target input copies. At 1000 input copies, primer/probe set analytical 224 efficiency ranged from 83% (E-Sarbeco) to 15% (US-CDC-N1) (Figure 2A ). At 100 copies, the 225 analytical efficiency hierarchy was identical, with values ranging from 74% (E Sarbeco) to 12% 226 (US-CDC-N1). Of all primer/probe sets evaluated, the E-Sarbeco, IP2 and IP4 sets had the 227 highest analytical efficiencies by a substantial margin. At 1000 and 100 target copies, E-Sarbeco 228 analytical efficiency was 83% (95% Total Poisson Confidence Interval [CI]: 79-87%) and 74% 229 (95% CI: 63-84%), respectively; IP2, analytical efficiency was 70% (95% CI: 67-73%) and 230 55% (95% CI: 46-64%), respectively; and IP4 analytical efficiency was 69% (95% CI: 66-72%) 231 and 59% (95% CI: 50-69%), respectively. In contrast, analytical efficiency of the China-ORF 232 primer/probe set was only 46% and 39% at 1000 and 100 input copies, respectively, and the 233 analytical efficiencies of the remaining sets were less than 30% regardless of input copy number. 234

Furthermore, while measurement precision generally decreased at the lower template 235 concentration (35), the E-Sarbeco, IP2 and IP4 primer/probe sets were nevertheless among the 236 most precise, with coefficients of variation (CV) of less than 5% at 1,000 input copies and less 237 than 15% at 100 input copies ( Figure 2B ). Combined analytical efficiency and precision data 238 confirmed E-Sarbeco, IP2 and IP4 as the best-performing primer/probe sets in RT-ddPCR 239 ( Figures 2C and 2D ), so these were moved forward for further characterization. 240

Reduced analytical efficiency when IP2 and IP4 are duplexed in RT-ddPCR 241

As IP2 and IP4 were originally designed for duplexing in real-time RT-PCR (28), we 242 evaluated them in duplex for RT-ddPCR. Duplexing however decreased analytical efficiency, 243 from 70% to 52% (at 1000 input copies) and 55% to 37% (at 100 input copies) for IP2, and from 244 69% to 49% (at 1000 input copies) and 59% to 38% (at 100 input copies) for IP4 (Supplemental 245 Figure 2A ). Duplexing also decreased precision (Supplemental Figure 2B ). For IP2, CV 246 increased from 5% to 11% when duplexing at 1000 input copies, and from 15% to 25% when 247 duplexing at 100 input copies. For IP4, CV increased from 4% to 7% (1000 input copies) and 248 from 14% to 21% (100 input copies) with duplexing. Duplexing of these reactions is therefore 249 not recommended in RT-ddPCR, and all IP2 and IP4 assays were performed as single reactions. 250

Droplet digital PCR can achieve absolute target copy number quantification without a 252 standard curve. To investigate the linear dynamic range (LDR) of quantification of the E-253

Sarbeco, IP2 and IP4 assays, we set up 18 two-fold serial dilutions of synthetic SARS-CoV-2 254 RNA beginning at 114,286 copies/reaction (this copy number is obtained when 120,000 copies 255 are added to a 21µl reaction, of which 20µl is used for droplet generation) and ending with 2.32 256 copies/reaction. This input copy number range crosses nearly the entire manufacturer-257 recommended template input range for ddPCR reactions seeking to quantify the target of interest, 258 which is 1-100,000 copies/reaction (36). 259

The LDR of each assay was determined by iteratively restricting the range of 260 concentrations included in the linear regression of measured versus input SARS-CoV-2 RNA 261 copies to identify the range that maximized the R 2 value and minimized the residuals. For E-262 Sarbeco, the regression spanning 18.6-114,286 input SARS-CoV-2 RNA copies per reaction, an 263 approximately 6,100-fold concentration range, yielded an R 2 value of 0.9995 ( Figure 3A , left). 264

Restricting the linear regression to this range also minimized the residuals of all included data 265 points to ±0.065log 10 copies/reaction ( Figure 3A , right). The IP2 assay, while less efficient than 266 E-Sarbeco, had the same estimated LDR of 18.6-114,286 input copies/reaction ( Figure 3B, left) . 267

This produced an R 2 value of 0.9995 and residuals within ±0.065log 10 copies/reaction across the 268 LDR ( Figure 3B , right). The LDR of IP4 was estimated as 37.2-114,286 input copies/reaction, 269 an approximately 3,000-fold range, which yielded an R 2 = 0.9975 and produced residuals within 270 ±0.11log 10 copies/reaction across this range ( Figure 3C ). For all three assays, 114,286 input 271 copies/reaction should be considered a conservative estimate of the upper limit of quantification, 272 as saturation of the RT-ddPCR reaction or loss of linearity was still not achieved at this 273 concentration. 274

We next determined the lower limit of detection (LLOD) of the E-Sarbeco, IP2 and IP4 276 RT-ddPCR assays ( Figure 4 ). Probit regression analysis applied to serial dilutions of synthetic 277 SARS-CoV-2 RNA standards revealed the E-Sarbeco RT-ddPCR assay to be the most 278 analytically sensitive of the three, which is consistent with it also having the highest analytical 279 efficiency. Specifically, the estimated LLOD of the E-Sarbeco assay was 4.4 (95% Confidence 280

Interval [CI]: 2.4-5.7) SARS-CoV-2 RNA copies/reaction ( Figure 4A ). The estimated LLOD of 281 the IP2 assay was 7.8 (95% CI: 4.4-10.3) SARS-CoV-2 RNA copies/reaction ( Figure 4B ), while 282 that of IP4 was 12.6 (95% CI: 6.9-16.5) SARS-CoV-2 RNA copies per reaction ( Figure 4C ). 283

SARS-CoV-2 viral loads were measured in 48 confirmed SARS-CoV-2 positive samples 285

using the E-Sarbeco, IP2 and IP4 primer/probe sets (note that samples with original diagnostic 286 test C t values <19 required RNA extracts to be diluted up to 1:200 prior to quantification to 287 ensure that input copies measurements fell within each assay's LDR). The results revealed that 288 SARS-CoV-2 RNA in these biological samples varied over a 6.2 log 10 range ( Figure 5A ). 289

Average copy numbers measured using the E-Sarbeco assay (which targets the E gene) were 290 higher than those using the IP2 and IP4 assays (which target ORF1a and ORF1b, respectively) 291 ( Figure 5A ). This is consistent with assay analytical efficiency ( Figure 2 ) and in vivo coronavirus 292 RNA expression patterns, where transcripts covering the 3' end of the genome are more 293 abundant than those covering the 5' end (37-40). Specifically, the median E-gene copy number 294 was 5.1 (IQR 3.9-5.7) log 10 copies/µl extract compared to a median of 4.9 (IQR 3.9-5.5) 295 log 10 copies/µl extract for the IP2 target, and a median of 4.9 (IQR 3.9-5.6) log 10 copies/µl 296 extract for the IP4 target. SARS-CoV-2 E-gene, IP2 and IP4 copy numbers in biological samples 297 correlated strongly with one another (Spearman's ρ>0.99; p<0.0001 for all pairwise analyses; 298 Figure 5BCD ). Consistent with comparable ORF1a and ORF1b RNA transcript levels in vivo 299 (37, 38, 40), IP2 and IP4 copy numbers were also highly concordant (Lin's concordance 300 correlation coefficient, ρc=0.9996 [95% CI: 0.9993-0.9998]) ( Figure 5D ). Based on a recent 301 recommendation (9), we also report our results in terms of SARS-CoV-2 RNA copies per human 302 cell equivalents: results for E-Sarbeco spanned an 7-fold range from 1.05 to 7.3 log 10 SARS-303

CoV-2 RNA copies/1,000 human cells, with IP2 and IP4 log 10 copy numbers lower, as expected 304 (Supplemental Figure 3A ). The Spearman's correlation between absolute and human cell-305 normalized viral loads was strong (ρ=0.9717; p<0.0001; Supplementary Figure 3B ), which is 306 consistent with the assumption that the amount of biological material collected by 307 nasopharyngeal swabs is relatively consistent. 308

Finally, we characterized the relationship between C t values produced by a commercial 310 COVID-19 diagnostic platform and SARS-CoV-2 RNA copy numbers. We selected the 311

LightMix® 2019-nCoV real-time RT-PCR assay, E-gene target (Tib-Molbiol), implemented on a 312

LightCycler 480 (Roche Diagnostics) because commercial diagnostic reagents comprising the E-313

Sarbeco primer/probe set exist for this platform (27) and because it takes purified nucleic acids 314 as input, thereby allowing direct comparison of results from the same starting material (real-time 315

RT-PCR platforms that take biological material as input are suboptimal for such a comparison 316 because the onboard extraction introduces an additional variable). As the C t values reported for 317 the LightMix® assay are based on a 9µl extract input volume, our primary analysis reported ddPCR results in terms of SARS-CoV-2 copies equivalent (i.e. SARS-CoV-2 copies in 9µl of 319 extract), to allow direct conversion of C t values to absolute viral copy numbers. 320

Sample C t values ranged from 11.34-31.18 (median 18.69 .69]) using the 321 LightMix® assay. The relationship between C t value and SARS-CoV-2 RNA copy numbers was 322 log-linear, with an R 2 = 0.9990 ( Figure 6 ). Despite this strong relationship, inspection of the 323 residuals nevertheless suggested modest departures from log-linearity at the extremes of the 324 linear range (Supplementary Figure 4) . The relationship between C t value and absolute SARS-325

CoV-2 E-gene copies can thus be given by log 10 SARS-CoV-2 E gene copies equivalent = 326 -0.3038C t +11.7 ( Figure 6 ). That is, a C t value of 20 corresponds to 453,942 (i.e. 5.66 log 10 ) 327 SARS-CoV-2 RNA copies, while a C t value of 30 corresponds to 416 (i.e. 2.62 log 10 ) viral 328 copies. This equation also predicts that the C t values corresponding to the LLOQ and LLOD of 329 the E-Sarbeco RT-ddPCR assays are 34.8 and 36.84, respectively. When measured SARS-CoV-2 330 RNA copy numbers are expressed as human cell-normalized viral loads, the relationship with Ct 331 value is given by log 10 SARS-CoV-2 E gene copies/1,000 human cells = -0.3041C t + 10.8 332 (Supplemental Figure 5 ). An extract that yielded a C t value of 20 therefore is estimated to have 333 contained 48,978 (i.e. 4.69 log 10 ) SARS-CoV-2 RNA copies/1,000 human cells, while one with 334 C t value of 30 is estimated to have contained 45 (i.e. 1.66 log 10 ) copies/1,000 human cells 335 336

While real-time and droplet digital RT-PCR platforms both employ target-specific 338 primers coupled with fluorescence-based amplicon detection, there are key differences in 339 reaction chemistry (e.g. RT-ddPCR reagents must be compatible with water-in-oil droplet 340 partitioning) and probe chemistry (e.g. while real-time RT-PCR uses fluorescent quenchers, 341 ddPCR typically uses dark quenchers). As a result, assays developed for one platform may not 342 always translate seamlessly to the other. For example, ddPCR probes should ideally not have a 343

Guanine at their 5' end because this quenches the fluorescence signal even following hydrolysis 344 (36) but the HKU-N probe has a G at its 5' end (Table 1) . 345

It is perhaps therefore not surprising that the overall performance of the eight 346 primer/probe sets in RT-ddPCR did not exactly mirror that in real-time 42) . 347

Nevertheless, E-Sarbeco, IP2 and IP4, which represented the most efficient and precise 348 primer/probe sets for SARS-CoV-2 RNA quantification by RT-ddPCR are also among the most 349 efficient in real-time 42) . Our results also confirm previous reports of the E-350

Sarbeco primer/probe set performing well in 22) . Other primer/probe sets 351 however, notably US CDC-N1, HKU-ORF and China-ORF, did not perform as well in our RT-352 ddPCR assay compared to a previous report (10). One key difference is that, while we used 353 sequence-specific reverse transcription (with the reverse primer) in a one-step RT-ddPCR 354 reaction, the previous study featured an independent reverse transcription reaction primed with 355 random hexamers and oligo dT, which can yield higher efficiency than sequence-specific 356

priming (35, (43) (44) (45) , to generate cDNA for input into a ddPCR reaction. To our knowledge, ours 357 is the first study to evaluate IP2 or IP4 primer/probe sets in The analytical sensitivities of the RT-ddPCR assays reported here are nevertheless 359 comparable to existing estimates. The limit of detection of the BioRad SARS-CoV-2 ddPCR Kit 360 (20) is, for example, estimated at 150 copies/mL, which is comparable to our E-Sarbeco RT-361 ddPCR assay (estimated at 75.8 copies/mL assuming 100% extraction efficiency). Similarly, the 362

LLODs of the TargetingOne (Beijing, China) COVID-19 digital PCR detection kit (23) and a 363 multiplex assay that included the E-Sarbeco primer/probe set (22) were reported at 10 copies/test 364 and 5 copies/reaction, respectively, both comparable to the LLOD determined here. While a 365 number of studies have reported that RT-ddPCR can detect SARS-CoV-2 RNA in low viral load 366 clinical samples with higher sensitivity than real-time 21, [23] [24] [25] , our study was 367 not designed to evaluate this. Our estimated LLOD of 4.4 copies/reaction by RT-ddPCR using 368 the E-Sarbeco primer/probe set ( Figure 4 ) is in fact comparable to the LLOD reported for many 369 real-time RT-PCR-based COVID-19 diagnostic assays (46). 370

The ability to quantify SARS-CoV-2 viral loads in biological samples can advance our 371 understanding of COVID-19 biology, and RT-ddPCR offers an attractive platform (7, 8). Our 372 observation that, in a small convenience sample, both absolute and human cell-normalized (9) 373 SARS-CoV-2 loads spanned a more than 6 log 10 range confirms an enormous viral load range in 374 vivo (47) and suggests that some of the high viral load samples measured here were from 375 individuals with early and progressive infection (23, 48-50) or who were experiencing severe 376 disease (7, 8), though clinical information was unknown. Furthermore, our equation relating C t 377 values derived from a commercial diagnostic assay and SARS-CoV-2 RNA copy number means 378 that existing diagnostic test results can be converted to viral loads without re-testing samples. 379

While calibration of viral load measurements against all real-time RT-PCR platforms is beyond 380 our scope, this is achievable and in some cases data may already be available (23). 381

Some limitations merit mention. We only tested eight commonly-used SARS-CoV-2-382 specific primer/probe sets, and others may exist that adapt well to RT-ddPCR. Our assay 383 performance estimates should be considered approximate, as the manufacturer-reported 384 concentration of the synthetic SARS-CoV-2 RNA standards used in our study may vary by up to 385 20% error (Twist Bioscience, personal communication). Moreover, we solely evaluated a one-386 step RT-ddPCR protocol, and therefore assay performance estimates will likely differ from 387 protocols that feature independent cDNA generation followed by ddPCR. We could not precisely 388 define the upper boundary of the linear dynamic range of the E-Sarbeco, IP2 and IP4 RT-ddPCR 389 assays as linearity was maintained at the maximum input of 114,286 target copies/reaction, 390 which already exceeds the manufacturer's estimated upper range of quantification in a ddPCR 391 reaction (36). Our convenience panel of 48 SARS-CoV-2-positive diagnostic specimens also 392 likely did not capture the full range of biological variation in viral loads, though data from larger 393 cohorts (47) suggests that it was reasonably comprehensive. We also acknowledge that there is 394 measurement uncertainty with real-time RT-PCR C t values that may subtly affect the linear 395 relationship between C t value and RT-ddPCR-derived SARS-CoV-2 viral load described here. 396

Finally, our estimates of assay performance may not completely reflect those of the entire 397 diagnostic process, as the nucleic acid extraction step introduces additional inefficiencies. 398

In conclusion, primer/probe sets used in real-time RT-PCR-based COVID-19 diagnostic 399 tests can be migrated to RT-ddPCR to achieve SARS-CoV-2 RNA quantification with varying 400 analytical efficiency, precision and sensitivity. Of the primer/probe sets tested, the E-Sarbeco, 401 IP2 and IP4 sets performed best, where LLOQ and LLOD estimates for the E-Sarbeco assay 402 (18.6 and 4.4 copies/reaction, respectively) indicated that RT-ddPCR and real-time RT-PCR 403 have comparable sensitivity. Mathematical inference of SARS-CoV-2 copy numbers from 404 Precision of each primer/probe set, defined as the coefficient of variation (expressed as a percentage, CV%) of measured copies, is shown for reactions containing 1,000 and 100 input copies of synthetic SARS-CoV-2 RNA. (C). Plotting precision versus analytical efficiency at 1,000 input SARS-CoV-2 RNA copies identifies E-Sarbeco, IP2 and IP4 primer/probe sets as having analytical efficiencies >50% and CV (%) <15%. (D). Same as C, but for 100 input SARS-CoV-2 RNA copies. left: log 10 Measured SARS-CoV-2 RNA copies over serial dilutions of synthetic SARS-CoV-2 RNA standards ranging from 114,286 to 2.32 copies/reaction (shown as log 10 values), using the E-Sarbeco primer/probe set. Error bars indicate 95% Total Poisson Confidence Intervals for two merged replicates, where in some cases error bars are too small to visualize. The regression line joins all data points included in the LDR, where the lower boundary of the LDR represents the lower limit of quantification (LLOQ) of the assay. Data points that yielded undetectable measurements are set arbitrarily to -0.35log 10 Measured copies/reaction for visualization. right:

Log 10 Residuals, calculated as log 10 Measured SARS-CoV-2 RNA copies/reaction minus log 10 Calulated SARS-CoV-2 RNA copies/reaction from the LDR regression. Grey shading indicates data points outside the LDR. Residuals for data points that yielded undetectable measurements are arbitrarily set to -0.4 for visualization. (B). Same as A, but for the IP2 primer/probe set (C). Same as A, but for the IP4 primer/probe set. synthetic SARS-CoV-2 RNA from 47.6 to 0.74 input copies/reaction using the E-Sarbeco primer/probe set is analyzed using probit regression (solid black line; dashed line denotes the 95% confidence interval). The LLOD, defined as the concentration of SARS-CoV-2 RNA in a reaction where the probability of detection in the assay was 95%, was interpolated from the standard curve and is shown as a colored dashed line (B). Same as A, but for the IP2 primer/probe set (C). Same as A, but for the IP4 primer/probe set. Precision of each primer/probe set, defined as the coefficient of variation (expressed as a percentage, CV%) of measured copies, is shown for reactions containing 1,000 and 100 input copies of synthetic SARS-CoV-2 RNA. (C). Plotting precision versus analytical efficiency at 1,000 input SARS-CoV-2 RNA copies identifies E-Sarbeco, IP2 and IP4 primer/probe sets as having analytical efficiencies >50% and CV (%) <15%. (D). Same as C, but for 100 input SARS-CoV-2 RNA copies. . left: log 10 Measured SARS-CoV-2 RNA copies over serial dilutions of synthetic SARS-CoV-2 RNA standards ranging from 114,286 to 2.32 copies/reaction (shown as log 10 values), using the E-Sarbeco primer/probe set. Error bars indicate 95% Total Poisson Confidence Intervals for two merged replicates, where in some cases error bars are too small to visualize. The regression line joins all data points included in the LDR, where the lower boundary of the LDR represents the lower limit of quantification (LLOQ) of the assay. Data points that yielded undetectable measurements are set arbitrarily to -0.35log 10 Measured copies/reaction for visualization. right: Log 10 Residuals, calculated as log 10 Measured SARS-CoV-2 RNA copies/reaction minus log 10 Calulated SARS-CoV-2 RNA copies/reaction from the LDR regression. Grey shading indicates data points outside the LDR. Residuals for data points that yielded undetectable measurements are arbitrarily set to -0.4 for visualization. (B). Same as A, but for the IP2 primer/probe set (C). Same as A, but for the IP4 primer/probe set. . The probability of detecting SARS-CoV-2 RNA (%) in 1:2 in serial dilutions of synthetic SARS-CoV-2 RNA from 47.6 to 0.74 input copies/reaction using the E-Sarbeco primer/probe set is analyzed using probit regression (solid black line; dashed line denotes the 95% confidence interval). The LLOD, defined as the concentration of SARS-CoV-2 RNA in a reaction where the probability of detection in Figure 5 : Log 10 SARS-CoV-2 RNA loads in diagnostic specimens (A). SARS-CoV-2 E (green circles), ORF1a (red squares) and ORF1b (blue triangles) gene copy numbers, expressed as RNA copies/µl of nucleic acid extract. Line and bars indicate median and interquartile range, respectively. (B) Correlation between Log 10 SARS-CoV-2 E and ORF1a gene RNA copies/µl extract. (C). Correlation between Log 10 SARS-CoV-2 E and ORF1b gene RNA copies/µl extract. (D) Correlation and Concordance between Log 10 SARS-CoV-2 ORF1a and ORF1b gene RNA copies/µl extract.

Supplementary Figure 1 : All experiments using synthetic SARS-CoV-2 synthetic standards were performed in a consistent background of human nucleic acids to mimic a real human sample. Example experiment showing consistent levels of background human cells/µl extract (determined by dividing measured human RPP30 DNA copy number by two; black triangles), and human RNAse P RNA levels (grey squares) across a titration of SARS-CoV-2 synthetic RNA standards, measured using the E-Sarbeco primer/probe set (green circles). Error bars indicate 95% Total Poisson Confidence Intervals for two merged replicates, where in some cases error bars are too small to visualize. Grey (RNase P) and black (RPP30) dashed lines indicate copies measured control experiments lacking SARS-CoV-2 RNA. Analytical efficiency of SARS-CoV-2 quantification was evaluated for the IP2 and IP4 primer/probe sets when used in separate reactions (dark red and dark blue, respectively) and when duplexed (light red and light blue, respectively), in reactions containing 1,000 and 100 viral RNA input copies. Error bars represent 95% Total Poisson Confidence Intervals. (B). Same as A, but for assay precision (coefficient of variation, CV%). Supplemental Figure 5 : Relationship between SARS-CoV-2 RNA copies/1,000 human cells and C t value. Same data as shown in Figure 6 , but where the measured SARS-CoV-2 RNA copies/µl extract were normalized to copies/1,000 human cells. The linear regression is shown as a solid black line.

418 Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

Viral-load tests provide valuable answers

HIV-1 viral dynamics and viral load measurement: 422 implications for therapy

Plasma viral load and CD4+ 425 lymphocytes as prognostic markers of HIV-1 infection

Correlates and prognostic value of the first-phase hepatitis C virus RNA kinetics 428 during treatment

Direct Quantification of Genome Editing Efficiency 461 from Whole Cells Using SingleShot Cell Lysis Buffer and ddPCR Genome Edit 462 Detection Assays

Digital droplet PCR (ddPCR) for the detection 465 and quantification of HPV 16, 18, 33 and 45 -a short report

Droplet digital PCR quantification suggests that higher viral 469 load correlates with improved survival in HPV-positive oropharyngeal tumours

472 Development of a droplet digital PCR for detection and quantification of porcine 473 epidemic diarrhea virus

Comparison 475 between RT droplet digital PCR and RT real-time PCR for quantification of 476 noroviruses in oysters

Development 479 of a droplet digital RT-PCR for the quantification of foot-and-mouth virus RNA

A quantitative approach for measuring the 485 reservoir of latent HIV-1 proviruses

Bio-Rad SARS-CoV-2 ddPCR Kit, Qualitative assay 487 for use in the QX200 and QXDx Droplet Digital PCR Systems Instructions for Use

Sensitivity assessment of droplet digital PCR for SARS-CoV-2 detection

Sensitive detection and 492 quantification of SARS-CoV-2 by multiplex droplet digital RT-PCR

Microbiol Infect Dis

Quantitative Detection and Viral Load Analysis of 496 SARS-CoV-2 in Infected Patients

Puoti 500 M, Perno CF. 2020. Detection and quantification of SARS-CoV-2 by droplet digital 501 PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 502 patients

504 Comparison of qualitative and quantitative analyses of COVID-19 clinical samples